Assessing Fear of Thyroid Cancer in the General U.S. Population: A Cross-Sectional Study
Authors' conclusion
Thyroid cancer-specific fear is prevalent in U.S. adults particularly in females and those younger than 40 years.
Study context
- Population
- English-speaking adults (>17 years) in the U.S. registered with Prolific, surveyed August 2020; 50.4% female, 74.1% White, mean age 45 years (SD = 16 years)94.3% eligibility
- Participants
- 1,136 adults
- Outcome
- High level of thyroid cancer-specific fear (adapted eight-item breast cancer fear scale)
Methodological detailsonline survey, sample stratified to represent U.S. demographics, multivariate logistic regression
- Online survey
- Sample stratified to represent U.S. demographics
- Multivariate logistic regression
Main finding
As reported in the abstract
High thyroid cancer-specific fear
- Respondents with high thyroid cancer-specific fear
- 47.5%
- Age <40 years vs 65+
- multivariate OR 2.46 (95% CI 1.60-3.80)
- Female vs male
- 1.48 (multivariate OR, CI 1.13-1.93)
- Believing thyroid cancer is serious
- 2.71 (OR, CI 1.99-3.69)
- Believing cancer in general is serious
- 1.53 (OR, CI 1.13-2.08)
- Overestimated thyroid cancer incidence
- 1.64 (OR, CI 1.25-2.13)
- Believed high chance of developing cancer
- 1.70 (OR, CI 1.19-2.42)
Observational data: associations, not effects.
Original publication
Assessing Fear of Thyroid Cancer in the General U.S. Population: A Cross-Sectional Study. Thyroid. Published 19 December 2023. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →